Recurrent Ischemic and Hemorrhagic Stroke in Cameroon: A Case-Control Study

Table 2

Fisher’s exact and odds ratios of sociodemographic, clinical, and therapeutic factors associated with stroke recurrence.

Factor	Odds ratio	95% confidence interval	value
Male	0.68	0.27–1.73	0.49
Urban dwelling	1.04	0.40–2.67	0.94
Right handedness	0.23	0.16–0.33	0.02
Personal history
Alcohol consumption	2.26	0.89–5.77	0.11
Tobacco consumption	1.81	0.59–5.54	0.36
Sedentary lifestyle	1.28	0.50–3.28	0.65
Chronic kidney disease	0.73	0.08–6.85	0.98
Congestive heart failure	3.45	1.16–10.28	0.03
Diabetes	2.21	0.79–6.20	0.16
Gout	4.44	1.09–18.09	0.04
Hypertension	1.40	0.50–3.97	0.62
Family history of stroke	1.34	0.50–3.60	0.61
Presenting signs
Alternating hemiplegia	0.91	0.27–3.09	0.98
Aphasia	0.30	0.06–1.39	0.14
Cerebellar syndrome	1.61	0.14–18.66	0.57
Dysarthria	4.34	1.30–14.54	0.02
Facial palsy	3.96	1.49–10.51	0.01
Intracranial hypertension	0.31	0.04–2.54	0.44
Meningeal syndrome	0.74	0.66–0.84	0.57
Medication observance
Antidepressant	N/A	N/A	N/A
Antidiabetic	3.20	0.23–45.19	0.55
Antihypertensive	0.64	0.24–1.72	0.47
Aspirin	0.79	0.10–6.50	0.98
Statin	0.88	0.67–1.14	0.98